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dNTP(3'-OCH.0, a 3'-O-methyl derivative ofdNTP, is a chain terminator substrate for DNA synthesis cata- 
lyzed by AMV reverse transriptasc. The enzyme seems to be the only DNA polymerase susceptible to the 
inhibitor while all the other DNA polymerases tested are fully resistant o the nucleotide analog. The res- 
istant polymerases are: E. eoli DNA polymerase I, Klenow's fragment of DNA polymerase I, phage T 4 
DNA polymerase, calf thymus DNA polymerase ~,rat liver DNA polymerase [$ and calf thymus terminal 
deoxyribonucleotidyl transferase. 
DNA polymerase Terminal tran,~ferase Chain terminator Nucleotide analog 
1. INTRODUCTION 2. MATERIALS AND METHODS 
A wide variety of nucleoside 5'-triphosphates 
modified at the sugar moiety was tested as chain 
terminators for a number of polynucleotide syn- 
thesizing enzymes [1-14]. Among these we have 
found dNTP(3'-NH2) which is equally active 
against most of the tested DNA polymerases 
[7-12], araNTP(3'-NH2) which is active against all 
but E. coli DNA polymerase I [9,10], dNTP(3'-N- 
fluoroscaminyl) which is not inhibitory only for 
the terminal deoxyribonucleotidyl transferase [10], 
and dNTP(3'-N3) and araNTP(3'-N3) active 
against AMV reverse transcriptase [10,12]. 
Here, we tested dNTP(3 '-OCH3) and found that 
this analog was capable of base-specific DNA 
chain termination with RNA-dependent DNA 
polymerase (reverse transcriptase) only. This 
finding provides a putative way to discriminate the 
activity of the enzyme in the cell from that of DNA 
polymerases o~ and ~ as well as from the activity of 
terminal transferase. 
2.1. DNA synthesis 
DNA was synthesized by different DNA 
polymerases (reverse transcriptase inclusive) using 
a single-stranded DNA of either M13 mpl l  or 
recombinant M13 mp9 phages [15] with a 
[~zP]d(GTAAAACGACGGCCACT) primer kind- 
ly provided by Drs Chumakov and Chernov (In- 
stitute of Molecular Biology, Moscow). The 
reactions were run under optimal buffer conditions 
for each of the enzymes. For details, see [10,11]. 
DNA was synthesized with terminal transferase as 
in [10] using the same primer. The products of 
DNA synthesis were analyzed by electrophoresis in 
12-30% polyacrylamide g l under denaturing con- 
ditions. 
2.2. Enzymes 
DNA polymerase I was purified from E. coli 
NMI82 as described [16]. Klenow enzyme was pro- 
duced from DNA polymerase I according to [17]. 
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Fig.l. DNA synthesized from M13 mp9 recombinant phage [15] by reverse transcriptase, The nucleotide sequence of  
the product is: 
4} .ACTGTAACCT TGACCTCCAG GTTCAAGCAA TCCTCCCGCC TCAGCCCCCC 90 
91. AGGTAGCCTC TGACTACATG AGTGCTACCA CACCTGCCTA TTTCTTCCTA 140 
Nucleotides are numbered starting from the 5'-end of the primer. Nucleotide analogs used (in the tracks): (I) control, 
incubation without an analog, synthesis for 3 rain; (2,3) araATP(3*-NH2); (4,5) dATP(3'-OCH3); (6,7) dCTP(3 '-NH2); 
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DNA polymcrasc ~v (7 S) was purified as in [18]. 
Terminal transfcrasc was prepared according to 
the modified procedure of Chang and Bollum [19]. 
These enzymes were nearly homogeneous as 
revealed by electrophoresis in polyacrylamide gel, 
and contained no endonucleases a demonstrated 
by the resistance of supcrcoiled pBR322 DNA to 
overnight incubation with the enzyme preparation 
at 37°C under the conditions optimal for each en- 
zyme. Reverse transcriptase was purified according 
to [20]. The specific activity and concentrations of
stock enzyme solutions were as follows: DNA 
polymerase I, 60 U//~g, 20 U/,ul; Klenow enzyme, 
20 U/#g, 2 U/,ul; DNA polymerase o:, 5 U/,ug, 
0.4 U//A; terminal transferase, 20 U//~g, 2 U//A; 
reverse transcriptase, 7 U//xl. T4 DNA polymerase 
was from PI~ Biochemicals (USA); DNA 
polymerase Le (with an activity of  3 U/,ag, 
0.1 U//A) was kindly provided by Dr Atrazhev (In- 
stitute of Molecular Biology, Moscow). 
2.3. Nucleotide analogs 
dATP(3'-OCH3), dGTP(3'-OCH3), dUTP(3'-  
OCH3) and dCTP(3'-OCH3) were synthesized as 
described in [21]. 
The nucleotide analogs contained about 1°7o of 
unmodified nucleoside triphosphates. Besides 
dCTP(3'-OCH3) preparations contained an 
unidentified admixture (=5%) o f  nucleoside 
triphosphates more lipophilic than dCTP(3' 
OCH3). Most probably it is the 4-N-methyl 
derivative of dCTP. 
dNTP(3 '-F), araNTP(3'-NHz), dNTP(3 '-NH2) 
and dTTP(NHbio) were kindly donated by Dr 
Mikhailopulo (Institute of Bioorganic Chemistry, 
Minsk), Dr Papchikhin (Kuybyshev State Universi- 
ty) and Dr Krayevsky (Institute of Molecular 
Biology, Moscow). The properties of these com- 
pounds, their nomenclature and ability to inhibit 
DNA polymerases were described earlier [7-12]. 
dNTPs were from Sigma (USA); [ce-3zp]dNTP and 
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[y-32P]ATP were from Isotop (USSR); [o~-35S]thio - 
dATP was from Amersham (England). 
3. RESULTS AND DISCUSSION 
Figs 1 and 2 show that dNTP(3'-OCHs) is 
capable of terminating DNA synthesis catalyzed by 
reverse transcriptase with a correct ermination of 
the growing DNA chain at sites directed by the 
nature of a nucleotide base. The correct sequence 
pattern does not change when an excess of natural 
dNTPs is added after the analog has been incor- 
porated into the 3'-end of the DNA. It follows 
therefore that: (i) incorporation of the analog into 
the DNA chain is irreversible and (ii) prolongation 
of the terminated chain is impossible, dAMP(3'-  
OCH3), dGMP(3'-OCHs) and dUMP(3'-OCHs) 
are incorporated in place of dAMP, dGMP and 
dTMP as one can see from the comparison with 
data for the corresponding dNTP(3'-F) [8] or 
araNTP(3'-NH2) [9] and from the ability to read 
the correct DNA sequence from the electrophero- 
gram (figs 1 and 2). dCTP(3'-OCH3) is also highly 
inhibitory. It terminates the DNA chain correctly 
but the sequencing pattern on the gel (fig.2, track 
8) is shifted a little with respect o other nucleotide 
terminated patterns. Moreover, dCTP(3'-OCH3) 
produces a rather smeared pattern. 
It seems that dCTP(3' -OCH3) preparations con- 
tain an admixture of a nucleotide substrate which, 
being incorporated into the DNA chain instead of 
dCMP, makes the DNA electrophoretic mobility 
differ from that in the case of natural dCMP. Most 
probably, the nucleotide is a dCTP analog 
modified somewhere in the base. 
The presence of an admixture is confirmed by 
the results of experiments with the terminal 
transferase shown in fig.3. The enzyme cannot use 
dNTP(3'-OCH3) as a substrate since the analog 
does not prevent oligonucleotide elongation in the 
presence of dNTP (fig.3a, tracks 5,6). When SZp_ 
(8,9) dTTP(3' -NHbio). The reaction is initiated by adding 3.5 U reverse transcriptase to 20 ,ul of the medium containing 
0. l,ug single-stranded DNA, preannealed with the 3ZP-primer oligonucleotide and purified by A15 m agarose 
chromatography. The incubation medium contains: 50 mM Tris-HCl (pH 8.4), 10 mM MgClz, 50 mM KCI, 5 mM 
2-mercaptoethanol, 0.1 mM EDTA and 50 ,aM each of the four natural dNTPs. After 3 rain at 42°C an NTP analog 
is added to 1 mM concentration a d the mixture incubated for 30 min. Then the reaction is either terminated by cooling 
to -20°C (tracks 2,4,6,8) or prolonged for another 30 min interval after adding a mixture of all the four dNTPs to 
a concentration of 1 mM (tracks 3,5,7,9). 
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Fig.2. MI3 mpl l  DNA sequence with dNTP(3'-OCH3). The reaction conditions are as in fig. 1 except the 
concentrations: DNA, 0.5/zg/ml; reverse transcriptase, 0.1 U//zl; dNTP, 50/zM; nucleotide analogs, 1 mM. The 
reaction time is 30 rain everywhere but track 7. Here after the incubation with dUTP(3'-OCH3) for 30 rain, a mixture 
of dNTPs is added to a concentration f 0.5 mM for an additional 30 min. dNTP analogs in the tracks: (1) no analog; 
(2) araATP(3'-NH2); (3) dATP(3'-OCH3); (4) araGTP(3'-NH2); (5) dGTP(3'-OCH3); (6,7) dUTP(3'-OCH3); (8) 
dCTP(3'-OCHa). The DNA sequence is: 
31. CCCGGGGATC CTCTAGAGTC GACCTGCAGC CCAAGCTTGG CGTAATCATG 80 
81. GTCATAGCTG TTTCCTGTGT GAAATTGTTA TCCGCTCACA ATTCCACACA 130 
Nucleotide numbering starts from the 5'-end of the primer. 
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Fig.3. Incorporation of nucleotide analogs into the 3'-end of the primer. [~ZP]d(GTAAAACGACGGCCAGT) is 
incubated for 30 min at 37°C with terminal transferase in 5,ul medium containing: 100 mM K cacodylate buffer (pH 
6.8), 50 mM CH3COOK, 5 mM MgCla, 0.5 mM CoClz, 2 mM 2-mercaptoethanol, 200/~M dNTP analog. Terminal 
transferase, 0.1 U/,~I; primer, 0.2 #M (a) or 1/~M (b). After preincubation, the probes are diluted 10-fold with a fresh 
medium containing neither the primer nor a dNTP analog, and either frozen at -20°C (tracks 1,3,5,7) or incubated 
for an additional 30 min at 37°C after adding 1 mM dATP (a: 2,4,6,8) or 1 mM dCTP (b: 2,4,6). Tracks correspond 
to: (a) 1,2, no inhibitor; 3,4, dATP(3'-F); 5,6, dATP(3'-OCH3); 7,8, dATP(3'-NH2); 9, original primer; (b) 1,2, no 
inhibitor; 3,4, dCTP(3'-F); 5,6, dCTP(3'-OCH3); 7, 2,aM dATP + 10 ~M [o~-35S]thio-dATP; 8, original primer. 
oligonucleotide is preincubated with terminal 
transferase in the presence of either dATP(3' -  
OCH3) (fig.3a, track .5) or dCTP(3'-OCH3) 
(fig.3b, track 5), the oligonucleotide slowly elon- 
gates. The elongation is due to the presence of 
about 1% of the original dNTP in the analog pre- 
parations. With dCTP(3' -OCH) in contrast to 
dATP(3'-OCH3), the oligonucleotide elongated 
by one or two nucleotides displays duplicated 
lines (fig.3, track 5). Further elongation yields a 
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Fig.4. Influence of dNTP(3'-OCH3) on M13 mpl 1 DNA elongation and hydrolysis by DNA polymerases o:, I and T4. 
Experimental conditions are as described in fig.2. The enzyme and dNTP concentrations and the reaction time are 
different. (a) Tracks 1,2,3,4, DNA polymerase I, 0.5 U//A, l,aM dNTPs; 1, without inhibitor, 15 s; 2,3,4, 1 mM 
dATP(3'-OCH3), 30 s, 1 rain and 3 min, respectively. Tracks 5-8, T4 DNA polymerase, 0.5 U/,al; 1/~M dNTPs; (5) 
without inhibitor, 15 s; (6,7,8) 1 mM dATP(3'-OCH3), 30 s, 1 rain and 3 rain respectively. Tracks 9-11 DNA 
polymerase or, 2 U/probe; 10 ,aM dNTPs; (9) without inhibitor, 2 rain; (10) 1 mM araATP(3 '-NHz), 60 min; (11) 2 mM 
dATP(3'-OCH3), 60 rain. (b) [32p]DNA for the experiment is prepared by elongation of the riP-primer on M13 DNA 
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smeared pa:tern for the oligonucleotide prein- 
cubated with dCTP(3'-OCH3) in contrast to a 
sharp pattern produced after preincubation with 
dATP(3'-OCH3) (of. fig.3a and b, track 6). Each 
oligonucleotide preincubated with either dATP(3' - 
OCH3) or dCTP(3'-OCH3) elongated freely after 
adding a dNTP excess (fig.3a,b, track 6) indicating 
that dNTP(3'-OCH3) was not incorporated in the 
chain. Otherwise elongation of the chain blocked 
by the 3'-OCH3 group would hardly be possible. 
When a 3'-modified nucleotide such as dNTP- 
(3'-F) or dNTP(3'-NH2) is incorporated, elonga- 
tion does not occur (cf. fig.3a and b, tracks 3,4 and 
fig.3a, tracks 7,8). One can see a band doubling 
similar to that in the case of dCTP(3'-OCH3) in 
the experiment with a mixture of  dATP and cr- 
thio-dATP (fig.3b, track 7). 
Others of the tested DNA polymerases are fully 
resistant to dNTP(3'-OCH3). Fig.4a,b demon- 
strates autoradiograms obtained for E. coli DNA 
polymerase 1, phage Ta and calf thymus DNA 
polymerase or. Neither of the DNA polymerases i  
terminated with dNI'P(3' -OCH3). The same is true 
for DNA polymerase /5' from rat liver and for 
Klenow enzyme (not shown). Even DNA hydroly- 
sis, which is in general more sensitive to the ter- 
minator nucleotides [11] due to the absence of a 
competing natural substrate from the medium than 
the elongation reaction; is not inhibited by 
dNTP(3'-OCH3) in a sequence-specific manner. 
As can be seen from comparing tracks 5 and 9 with 
10 and 14 in fig.4b, dNTP(3'-NH2) and ddNTP 
virtually do not terminate the synthesis in the 
presence of 1 mM natural dNTPs although they 
rather effectively terminate DNA hydrolysis in the 
absence of a natural substrate. The same is true of  
araNTP(3'-NH2) and DNA potymerase I [11]. 
The results of this work suggest that 
dNTP(3'-OCH3) can be used for selective'inhibi- 
tion of DNA synthesis catalyzed by reverse 
transcriptase. Preliminary experiments with a mix- 
ture of enzymes, either DNA polymerase ce and 
reverse transcriptase or Klenow enzyme and 
reverse transcriptase, have shown that the presence 
of an enzyme unable to utilize a certain nucleotide 
analog does not prevent chain termination by the 
enzyme which is inhibited by this analog, 
Therefore, one may expect hat the above analogs 
can be used in studying the role of reverse 
transcriptase in both normal and transformed 
cells. 
Comparison of the data presented here with 
those concerning other nucleotide analogs 
modified at the sugar moiety [8-12] clearly 
demonstrates that the viral reverse transcriptase 
possesses lower substrate specificity than any 
cellular DNA polymerase~tes~te.d._The conclusion, 
extrapolated to other DNA polymerases of viral 
origin, opens up a wide variety of nucleotide and 
nucleoside analogs for testing as putative drugs 
against any disease which requires reproductive 
retrovirus (or other virus) infection dependent on 
activity of the virus encoded polymerase. 
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